Lexaria Bioscience Corp.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2024
Total Assets: $8.9M
Liabilities Breakdown FY2024
Total Liabilities: $1.2M
Asset Breakdown
Total Assets: $8.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $6.5M | 73.3% |
| Accounts Receivable | $154.5K | 1.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $254.7K | 2.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $516.7K | 5.8% |
| Other Assets | $1.4M | 16.3% |
Liabilities Breakdown
Total Liabilities: $1.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.1M | 88.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $142.3K | 11.8% |